Smith & Nephew (SNN) Interest & Investment Income (2016 - 2024)

Smith & Nephew (SNN) posted quarterly Interest & Investment Income of $9.0 million for Q4 2024, up 126.47% year-on-year from $4.0 million in Q1 2024, and up 126.47% on a QoQ basis from -$34.0 million in Q4 2023.

Smith & Nephew (SNN) Interest & Investment Income (2016 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Interest & Investment Income for 9 consecutive years, with $9.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Interest & Investment Income rose 126.47% year-over-year to $9.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$19.0 million (up 24.0% YoY) and the FY2025 annual result came in at $28.0 million, up 16.67% from the prior year.
  • Interest & Investment Income improved to $9.0 million in Q4 2024 per SNN's latest filing, from -$34.0 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for SNN reached as high as $9.0 million in Q4 2024 and fell as low as -$34.0 million in Q4 2023.
  • A 5-year average of -$3.2 million and a median of $3.0 million in 2020 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2023 — Interest & Investment Income tumbled 1233.33% — and 2024, when it surged 126.47%.
  • Year by year, Interest & Investment Income stood at $3.0 million in 2020, then changed by 0.0% to $3.0 million in 2021, then changed by 0.0% to $3.0 million in 2022, then slumped by 1233.33% to -$34.0 million in 2023, then jumped by 126.47% to $9.0 million in 2024.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $9.0 million, -$34.0 million, and $3.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 106.00 Mn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 33.50 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 40.98 Mn
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 9.00 Mn
Dec 31, 2023 -34.00 Mn
Dec 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
Dec 31, 2020 3.00 Mn
Dec 31, 2019 5.00 Mn
Dec 31, 2018 4.00 Mn
Dec 31, 2017 3.00 Mn
Dec 31, 2016 2.00 Mn